Mount Sinai School of Medicine - December 2009

Clinical Trial of TSO for Autism Recruiting

http://clinicaltrials.gov/ct2/show/NCT01040221

This will be a 16 week, open-label trial of TSO to assess the effect on repetitive behaviors, aggression and irritability, and global functioning in adults with autistic disorder. The objectives of the proposed study are to develop an innovative treatment approach to autism by 1) assessing the safety and efficacy of TSO treatment using behavioral and laboratory outcome measures; 2) determining whether this treatment has sufficient promise to warrant consideration of a larger, multi-centered, placebo-controlled clinical trial; 3) conducting secondary analyses to explore the relationship between clinical features, immune mechanisms, and treatment response.

06/21/2010

OCD Immune link

OCD behavior in mice has been linked to the Hoxb8 gene. Hoxb8 is found in … read more >

06/21/2010

Article about TSO therapy in BusinessWeek

This article about helminth and TSO therapy appeared recently in BusinessWeek (Now Bloomberg BusinessWeek) magazine. … read more >

09/23/2009

Major TSO Allergy Study in Press

A major double-blind, placebo controlled study of TSO therapy for allergic rhinitis is complete and … read more >

08/05/2009

TSO To Be Studied At Seaver Center

The Seaver Autism Center for Research and Treatment at Mount Sinai is interested in testing … read more >